1H-Benzimidazol-6-amine,1-ethyl-5-fluoro-2-methyl-(9CI)(712-03-8)
- Name: 1H-Benzimidazol-6-amine,1-ethyl-5-fluoro-2-methyl-(9CI)
- Synonyms:1H-Benzimidazol-6-amine,1-ethyl-5-fluoro-2-methyl-(9CI)
- Molecular Formula:C10H12FN3
- Molecular Weight:193.22
- CAS Registry Number:712-03-8
- EINECS:
- Melting Point:
- Water Solubility:
CAS No.712-03-8 1H-Benzimidazol-6-amine,1-ethyl-5-fluoro-2-methyl-(9CI)
Assay:99% Appearance:powder or liquid Package:according to customer requirements Storage:store in dry dark and ventilated place Transportation:By Sea/Air/Courier Application:It is an important raw material.
Min. Order:10Gram
Supplier:Zibo Hangyu Biotechnology Development Co., Ltd [
China (Mainland)] CAS No.712-03-8 1H-Benzimidazol-6-amine,1-ethyl-5-fluoro-2-methyl-(9CI)
Assay:99.0% Appearance:liquid Package:Grams, Kilograms Storage:Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials. Transportation:According to customer request Application:For R&D and commerical use
Min. Order:100Gram
Supplier:Chemlyte Solutions [
China (Mainland)] CAS No.712-03-8 1H-Benzimidazol-6-amine,1-ethyl-5-fluoro-2-methyl-(9CI)
Assay:99% Package:box or opp package Storage:cool drum Transportation:air or sea Application:1H-Benzimidazol-6-amine,1-ethyl-5-fluoro-2-methyl-(9CI)
Min. Order:1Milligram
Supplier:weifang yangxu group co.,ltd [
China (Mainland)] CAS No.712-03-8 1H-Benzimidazol-6-amine,1-ethyl-5-fluoro-2-methyl-(9CI)
Assay:99% Application:It is an important raw material.
Min. Order:0
Supplier:Shandong Mopai Biotechnology Co., LTD [
China (Mainland)]
Other Product
- 606116-00-1/1,2,3-Thiadiazole-4-carboxamide,N-[2-(cyclohexylamino)-2-oxoethyl]-N-(2-phenylethyl)-(9CI)
- 606116-01-2/1,2,3-Thiadiazole-4-carboxamide,N-[2-[(1,1-dimethylethyl)amino]-2-oxoethyl]-N-(2-methoxyethyl)-(9CI)
- 709-58-0/1-NITRO-3-(TRICHLOROMETHYL)BENZENE
- 606116-02-3/1,2,3-Thiadiazole-4-carboxamide,N-[2-(cyclopentylamino)-2-oxoethyl]-N-(2-methoxyethyl)-(9CI)
- 677752-05-5/1,3-Dioxaspiro[4.4]nonan-6-ol,2,2,4-trimethyl-7-methylene-,(4S,5S,6S)-(9CI)
- 709-69-3/Benzoic acid, 4-(fluorocarbonyl)-, methyl ester (9CI)
- 678981-20-9/Spiro[4.5]dec-7-en-1-ol, 1,6,8-trimethyl- (9CI)
- 678981-36-7/Spiro[5.5]undecan-1-ol, 7-ethyl-11-methyl- (9CI)
- 60838-00-8/2-Furancarboxylicacid,5-cyano-,methylester(9CI)
- 606116-50-1/Pyrazolo[1,5-a]pyrimidin-7-ol, 2-(3,5-dimethoxyphenyl)-5-phenyl- (9CI)
- 60816-50-4/D-GLUCOSE 6-PHOSPHATE BARIUM SALT
- 677755-25-8/1H-Indole-2,3-dione,5-ethyl-,3-(methylhydrazone)(9CI)
- 606116-04-5/1,2,3-Thiadiazole-4-carboxamide,N-cyclopropyl-N-[2-[(1,1-dimethylethyl)amino]-2-oxoethyl]-(9CI)
- 677761-35-2/Pyrazolo[5,1-b]thiazol-7-amine, 6-methyl-
- 606116-05-6/1,2,3-Thiadiazole-4-carboxamide,N-[2-(cyclopentylamino)-2-oxoethyl]-N-cyclopropyl-(9CI)
- 677761-40-9/1H-Imidazo[1,2-b]pyrazol-7-amine,1-methyl-(9CI)
- 677762-00-4/3-Pyridinecarboxylicacid,1-ethyl-1,6-dihydro-6-oxo-(9CI)
- 606116-07-8/1,2,3-Thiadiazole-4-carboxamide,N-[2-(cyclopentylamino)-2-oxoethyl]-N-2-propenyl-(9CI)
- 60826-26-8/3-Acetoxydodecane
- 712-03-8/1H-Benzimidazol-6-amine,1-ethyl-5-fluoro-2-methyl-(9CI)
- 677751-79-0/2-Cyclopenten-1-one, 4,5-dihydroxy-4-[(1R)-1-hydroxyethyl]-, (4R,5S)- (9CI)
- 677751-80-3/2-Cyclopenten-1-one, 4,5-dihydroxy-4-[(1S)-1-hydroxyethyl]-, (4R,5R)- (9CI)
- 677751-81-4/2-Cyclopenten-1-one, 4,5-dihydroxy-4-[(1S)-1-hydroxyethyl]-, (4R,5S)- (9CI)
- 677751-84-7/Spiro[1,3-dioxolane-4,2-[6]oxabicyclo[3.1.0]hexane], 2,2,5,5-tetramethyl-, (1S,2R,5R,5S)- (9CI)
- 677751-94-9/Spiro[1,3-dioxolane-4,2-[6]oxabicyclo[3.1.0]hexane], 2,2,5,5-tetramethyl-, (1S,2R,5S,5S)- (9CI)
- 677751-95-0/Spiro[1,3-dioxolane-4,2-[6]oxabicyclo[3.1.0]hexane], 2,2,5,5-tetramethyl-, (1R,2R,5S,5R)- (9CI)
- 60816-17-3/Cholesterol-26,26,26,27,27,27-D6
- 677752-10-2/1,3-Dioxaspiro[4.4]nonan-6-ol,2,2,4-trimethyl-7-methylene-,(4S,5S,6R)-(9CI)
- 606116-03-4/1,2,3-Thiadiazole-4-carboxamide,N-[2-(cyclohexylamino)-2-oxoethyl]-N-(2-methoxyethyl)-(9CI)
- 677752-15-7/1,3-Dioxaspiro[4.4]nonan-6-ol,2,2,4-trimethyl-7-methylene-,(4R,5S,6R)-(9CI)